|
Active substance |
COR-003 (2S,4R-ketoconazole) |
|
Holder |
Cortendo AB |
|
Status |
Closed |
|
Indication |
Endogenous Cushing’s Syndrome |
|
Public documents |
|
|
Last update |
11/08/2020 |
COR-003 (2S,4R-ketoconazole)
Last updated on 10/09/2024